Government–donor–academia collaboration model in the pharmaceutical regulatory system and considerations for sustainability in low- and middle-income countries

Rima S. Saleh, Rita Karam, Lynn Adaimy, Chadi Baalbaki

Open source

DOI
10.1108/ijhcqa-12-2025-0220
Published
2026-07-24
Container
International Journal of Health Care Quality Assurance
Publisher
Emerald
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1108/ijhcqa-12-2025-0220,
  title = {Government–donor–academia collaboration model in the pharmaceutical regulatory system and considerations for sustainability in low- and middle-income countries},
  author = {Rima S. Saleh and Rita Karam and Lynn Adaimy and Chadi Baalbaki},
  year = {2026},
  journal = {International Journal of Health Care Quality Assurance},
  doi = {10.1108/ijhcqa-12-2025-0220},
  url = {https://doi.org/10.1108/ijhcqa-12-2025-0220}
}

RIS

TY  - JOUR
TI  - Government–donor–academia collaboration model in the pharmaceutical regulatory system and considerations for sustainability in low- and middle-income countries
AU  - Rima S. Saleh
AU  - Rita Karam
AU  - Lynn Adaimy
AU  - Chadi Baalbaki
PY  - 2026
JO  - International Journal of Health Care Quality Assurance
DO  - 10.1108/ijhcqa-12-2025-0220
UR  - https://doi.org/10.1108/ijhcqa-12-2025-0220
ER  - 

APA

Saleh, R. S., Karam, R., Adaimy, L., & Baalbaki, C. (2026). Government–donor–academia collaboration model in the pharmaceutical regulatory system and considerations for sustainability in low- and middle-income countries. International Journal of Health Care Quality Assurance. https://doi.org/10.1108/ijhcqa-12-2025-0220

Source records